My Philosophy on Earnings

This is still a healthy market. I’ve been researching AFOP and like what I see, especially the rumor that GOOG is a 40% client, due to its fiber rollout. With the stock off 6 from its high, I like it heading into earnings.

The key phrase there is “heading into earnings,” but not the earnings itself. As a matter of fact, there are very few companies that I want to own during earnings. Based on recent history (e.g. BBY), the market has been unforgiving to any company, with exception to AMZN, that misses. Being at new highs and all, any company that misses will likely catch a 20-30% gravity-hammer to the skull, crushing investors to pieces.

Isn’t it better to simply wait for the turmoil to pass, letting “the others” step on the landmines for you?

I couldn’t be happier than right now, seeing BBY down 30% on the news that it is a horrible store. Now if CONN and HGG could just got to zero already, I could consider myself “a fortunate man.” Bear in mind, I do not stand to profit from this debacle, monetarily. But payment of the soul is far more valuable and I truly enjoy seeing people get their “comeuppance.”

Let’s just throw it out there, shall we? It was a horrible holiday season. No one wants to buy stuff from stores anymore, when AMZN is fixing to deliver wares via mini-helicopters.

In the pre-market, shippers and solar stocks are lifting. The Dry Bulk index is bouncing hard and Jennifer is losing money, yet again, short BALT, post 40% decline in the BDI. It goes to show you, and let this be a lesson to many of you: even if you had tomorrow’s newspaper today, that doesn’t mean you can confidently predict how Wall Street will digest said news.

Earlier today I got to looking at this market, I mean really looking at it, and was disgusted by what I saw. Chinese stock after chinese stock up 50% over the past few weeks. Solar and alternative energy names up double figures in weeks. Biotech hand grenades up triple digits over the past few days. I’ve seen this story before and it always ends with my penis barely escaping the guillotine.

Although I am bullish and believe February will bring us fruits to eat and slobber about our faces with, I am skeptical because it is my nature to be this way. Deep down, I am a very dark, sinister, almost evil, person, parlaying stock ideas for fun because the internet belongs to me. The bold truth is, I am a seller. Do not ask me “what are you selling Fly?” Just know, that I am a seller, of extreme proportions. I cannot find anything to buy. I’d rather be confined to a wheeled chair than be forced to buy NFLX upwards of $300. God save me.

I am in a very dire and dour mood, even though I am hitting new highs, managed my sales at the highs of the session, and made more money today than 95% of people make in a year. Even still, I brood listening to ridiculous music from the 14th century, angry because of reasons unbeknownst to me. Truly.

I don’t even know what that is. But I’m doing it anyway.

I am raising cash here because I don’t have any place to put money. Nothing is screaming out to me now, so I might as well take a breather.

Aside from RPTP, there is another biotech that I am very interested in; but it’s up a lot today and I was hoping to buy it lower.

Having said that, the market looks great and there isn’t a reason to sell now. I tend to get uneasy when stocks become very predictable. Also, the last thing in the world that want to do is ride these suckers into earnings.

No thanks.

I am not a stupid man. Therefore, I am taking some profits here, selling TXTR post recovery. I have no interest in battleground stocks when everything is trading up.

Sellers of ICPT got it wrong.

When I asked my expert source about ICPT at $40, he laughed and said their liver drug was “impossible.” Well, studies have proved him wrong and he’s acknowledged the huge potential in NASH. A few days ago, there was some news out that said ICPT’s drug might cause a “fatty liver.” Look, I only play Doctor on the internets, doing surgery for fun because they gave me a scalpel. I don’t pretend to know the first thing about biotech. I am fully dependent upon real doctors with real degrees from North America. But ICPT is going to break $800 one day– and anything that works with their drug will run in tandem. WRITE IT DOWN!!! (screaming at the top of my lungs, despite it being very early in the morning)

It just so happens that RPTP has such a wonderful drug.

2014 is “The Year of the Liver.” While you wrestle with your erectile dysfunction issues, real people are in need of real livers, mostly due to alcohol abuse and/or excessive ingestion of harsh chemicals like “green tea.” We all need livers and would like to drink and smoke, AD HOC, without having to worry about superfluous liver enzyme issues, which may or may not lead to death.

As I write this, that stupid bastard, Mr. Wonderful from “The Shark Tank”, is on the teevee and that annoys me. I’ve lost interest in continuing this post.

Top pick: RPTP

You lost a great deal of money today. You are probably wondering why I still bother addressing the bears, men like Jennifer cavorting about the internets, warning people of impending doom. The truth is, I rather enjoy poking fun at you, the stupidest people of society, clad in burlap garments and velcro laced sneakers–because laces are simply “too hard”.

This is easy. Buy the dips and drink the blood. Spend your money judiciously and save for a rainy day.

The skies are clear now and the sun is electrifying, in the middle of winter, burning melanoma into the skin of the unprotected.

I bought GOGO towards the end of the day and will buy more if it hits $20.

NOTE: RPTP is now my largest holding.

Chartsists hate it. I like it.

I added to my position sub $23.

You didn’t think the market would trade lower again, did you?

You make this too easy for me. It’s like stealing the false teeth from an old lady in a wheeled chair at a red light. The NASDAQ is flying and my positions, save GOGO, are punching higher. I’ve made back plenty of losses and am now well on my way towards victory, of the unadulterated sort–if there is even such a thing.

From the watch list, CLDX is ripping bras and breasts off.

Look at TXTR, in all of its sublime grandeur, crushing the minds and spirits of the lemonade salesmen over at Citron Research. And, again, have a quick glance (DO NOT STARE!!!) at my RPTP, which has been my 2nd largest position for several days now.

Lastly, take out your “beer goggles” and have a gander at BALT, up on the day, even though Capesize rates have basically dropped to nothing, fulfilling the prophecy of Jennifer, yet no one seems to care.